Description:This patent is directed to compositions and methods for treating parasitic infections. Compounds have been identified from a library of anti-cancer drugs that serve as suitable agents for targeting trypanosomatids. Certain aspects of this invention are directed to methods of treating eukaryotic parasites (Leishmania major or Trypanosoma cruzi) by administering an effective amount of a derivative.
Abstract:Embodiments are directed to compositions and methods for treating parasitic infections. Compounds have been identified from a library of anti-cancer drugs that serve as suitable agents for targeting trypanosomatids.
Issue Date: 06/06/2017
Application Date: 06/27/2016
Post Date: 02/28/2018
UTEP Docket No: 2013-023
